ABCB1 and cancer: To investigate the effects of trametinib on ABCB1-mediated MDR in cancer cells, we firstly examined the cytotoxicity of trametinib in two ABCB1-overexpressing cells KBV200 and MCF-7/ADR and their parental cells KB and MCF-7 by MTT assay.